(Total Views: 627)
Posted On: 05/22/2020 11:02:38 AM
Post# of 153907
HIV Drugs in Clinical Trials to Treat COVID-19—What You Need to Know
Excerpt:
There is another investigational HIV drug soon to enter a clinical trial for COVID-19, this one in an entirely new class of drugs. Leronlimab is a monoclonal antibody. Leronlimab binds to a protein on the surface of human CD4 cells called CCR5—a receptor that HIV hijacks to enter human CD4 cells—thereby preventing HIV from entering the CD4 cell.
The drug is manufactured by Oregon-based CytoDyn, Inc., and leronlimab is the only drug in their pipeline at this time. In addition to a phase 2 trial for COVID-19, leronlimab is in phase 3 trials for HIV, and in various phases of trials for a number of cancers and some autoimmune conditions, including Crohn’s disease and multiple sclerosis.
https://www.thebody.com/article/hiv-drugs-cli...t-covid-19
Excerpt:
There is another investigational HIV drug soon to enter a clinical trial for COVID-19, this one in an entirely new class of drugs. Leronlimab is a monoclonal antibody. Leronlimab binds to a protein on the surface of human CD4 cells called CCR5—a receptor that HIV hijacks to enter human CD4 cells—thereby preventing HIV from entering the CD4 cell.
The drug is manufactured by Oregon-based CytoDyn, Inc., and leronlimab is the only drug in their pipeline at this time. In addition to a phase 2 trial for COVID-19, leronlimab is in phase 3 trials for HIV, and in various phases of trials for a number of cancers and some autoimmune conditions, including Crohn’s disease and multiple sclerosis.
https://www.thebody.com/article/hiv-drugs-cli...t-covid-19
(0)
(0)
